Evidence map›Paper›PMID 34199820›Full record

ReviewFoods (Basel, Switzerland)2021

Natural Food Polysaccharides Ameliorate Inflammatory Bowel Disease and Its Mechanisms.

Yikun Wang, Haibin Zhu, Xiaoji Wang, Yue Yu, Jianhua Xie

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
8.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Porphyran fromMarine drugs · 2023
    Article
  9. Review
  10. Review
  11. In Vitro Fecal Fermentation ofFoods (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yikun WangQueen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
Haibin ZhuState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Xiaoji WangSchool of Chemical Engineering and Energy Technology, Dongguan University of Technology, Dongguan 523808, China.
Yue YuState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang 330047, China.
Jianhua XieQueen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.ORCID 0000-0002-3906-1260
Nanchang University · CNDongguan University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural polysaccharides and their metabolites' short chain fatty acids (SCFAs) have attracted much attention. Recently, they have shown great potential in attenuating systemic inflammation activities, especially in inflammatory bowel disease (IBD). IBD is a complex pathological process and is related to epithelial damage and microbiota imbalance in the gut. Recent studies have indicated that natural polysaccharides could improve IBD recovery by different mechanisms. They could not only influence the ratio of intestine microbiota, but also regulate the secretion levels of immunity cytokines through multiple pathways, the latter including modulation of the TLR/MAPK/NF-κB signaling pathways and stimulation of G-protein-coupled receptors. Moreover, they could increase intestinal integrity and modulate oxidative stress. In this review, recent research about how natural polysaccharides impact the pathogenesis of IBD are summarized to prove the association between polysaccharides and disease recovery, which might contribute to the secretion of inflammatory cytokines, improve intestine epithelial damage, reduce oxidative stress, sustain the balanced microenvironment of the intestines, and finally lower the risk of IBD.

Indexed as

inflammatory bowel diseasemechanismpolysaccharides

Identifiers

PMID34199820
PMCPMC8227517
OpenAlexW3170162444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.